Basic Information
The Revista Brasileira de Medicina do Esporte (RBME in its Portuguese form) is an official organ of the Sociedade Brasileira de Medicina do Exercício e do Esporte (SBME) Brazilian Society of Exercise Medicine and Sports) and represents the main promotion resource of the scientific production in the Exercise Sciences and Sports Medicine (SBME) fields in our country. The RBME was launched in 1995 with trimester periodicity and became regularly bi-monthly published with no interruptions from 1999. RBME is an inter-and multidisciplinary, peer reviewed, Open Access journal which accepts contributions from the national and international scientific community. RBME publishes original articles of high scientific relevance in Exercise and Sports Medicine, review articles, and systematic reviews. RBME preferably publishes original articles of international interest, not only of regional significance. Its goal is to disseminate the scientific production in the areas of exercise and sports medicine through the publication of original research results and other documents that contribute to the scientific and applied knowlewdge of physical activity, exercise and sports, within the framework of biological sciences and medicina. Its title abbreviation is Rev Bras Med Esporte, which should be used in references, footnotes and reference subtitles. |
Mission
The RBME mission is to disseminate scientific production in the Exercise and Sports Sciences fields through the publishing of results of original research as well as other data which contribute to the basic and applied knowledge in Physical Activities, Exercise and Sports in the Biological Sciences and Medicine scenario. |
Index Sources
RBME is indexed in the following bases:
|
Intellectual property
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type CC-BY. |
Sponsors
A Revista Brasileira de Medicina do Esporte – RBME recebe apoio do (a):
|
Editors
Editor-in-chief
Scientific Editor
|
Associate editors
Sports Medicine applied to Rehabilitation
Sports Medicine applied to Exercise
Sports Medicine applied to Cardiology
Sports Medicine applied to Traumatology and Orthopedics
Sports Medicine applied to Clinical Medicine
Sports Medicine applied to Epidemiology
Sports Medicine applied to Adaptive Sports
Sports Medicine applied to Nutrology
|
Publishing Committee
National Members
International members
|
Advisory Editor
|
Executive Editor
|
Managing Editor
|
Publishing Production
Publishing coordination, creation, copydesk and graphic design:
|
Scope and Policies
The Revista Brasileira de Medicina do Esporte (RBME) (Brazilian Journal of Sports Medicine), the official publication of the Brazilian Society of Exercise and Sports Medicine (SBMEE), English . RBME is indexed in the following bibliographic databases: SciELO, Web of Science, Excerpta Medica-EMBASE, Physical Education Index, LILACS, SIRC-Sportdiscus, and Scopus. i s a continuous publication, with no periodic closing of editions, with versions in Portuguese andThe publication fully adheres to the international recommendations of the International Committee of Medical Journal Editors (ICMJE), commonly referred to as the Vancouver Convention, and its standardization requirements. Publication Fee: To ensure the sustainability and continuity of RBME, we inform authors that an article publishing fee was introduced in January 2014. Authors are now required to pay a fee for articles accepted for publication. This fee will be charged upon approval of the article. Following acceptance of the manuscript and notification by the editor-in-chief, the author(s) must make a bank deposit in the name of the Associação Brasileira de Medicina do Esporte (Brazilian Association of Sports Medicine), CNPJ (Corporate Taxpayer’s ID) 30.504.005-0001-12, Bradesco Bank, Agency 0449, Account number 0001353-6. The receipt of deposit should then be sent to the email address atharbme@uol.com.br, stating the protocol number of the work (RBME-0000), the title of the article, and the name of the corresponding author. This publication fee is R$2000 (US$600) for articles submitted to the English or Portuguese versions of the journal. Translation Rate: RBME is published in three versions: English and Portuguese. Articles may be submitted in Portuguese and/or English. If an article is approved, it must then be submitted in the other language if the original submission was in one language only. Thus, if the article was submitted in English, a version in Portuguese must be sent, and vice versa. If the author would like the translation be arranged by RBME, a request must be made within five days. Otherwise, the author must submit the translated version within twenty-five days after the notification of acceptance for publication (see the translation fees and other information in the tables below). If the second language is not delivered within the time stipulated, the article will be canceled.
Therefore, for approved articles, translation into the other language is compulsory. We recommend sending the articles in both languages in the initial submission to facilitate production. Any changes requested by the author after the article has been accepted and is in the editing phase must be made to both versions.
If the translated version is not received within twenty-five days, the publication of the article will be cancelled.
On submission of the manuscript, after filling out the registration form, the author must read and agree to the terms of originality, relevance and quality, and to the payment of the applicable fees. Once these obligations have been acknowledged, the manuscript will be registered in the system for evaluation. If payment is not received within seven days, from the date of receipt of the communication of acceptance of the article for publication, this will result in the publication of the article being canceled. |
Manuscript outlining and preparation
Instructions for Submission of Articles: Articles must be submitted directly via the SciELO online submission system. The following supplementary documents should be submitted together with the article: (1) Term of Disclosure of Potential Conflicts of Interest; (2) Declaration of Originality; and (3) Statement of Authors' Contribution, with the ORCID (Open Researcher and Contributor ID) number of each author; (4) Certification of translation of the English version by a professional translator. Articles or supplementary documents submitted by email, post, or any means other than to the electronic address mentioned above will not be accepted. Plagiarism: RBME adopts Similarity Check/Ithenticate plagiarism detection system. Nevertheless, all content published in the articles is the authors’ sole responsibility. Should plagiarism be detected, in any form, the authors of the submitted article will be contacted by RMBE and asked to provide an explanation. If any plagiarism comes to light after the journal is published, the article in question will not be withdrawn from the edition; an addendum of plagiarism will be affixed to the publication, with explicit identification on the cover sheet in a full-sized strip detailing the content. The Journal will not be responsible for notifying the original author about the plagiarized content. Conflict of Interest: The author should make explicit any potential conflict of interest related to the submitted article, in accordance with the rules of the National Health Surveillance Agency (RDC 102/2000) and the Federal Board of Medicine (Resolution no. 1.595/2000). The purpose of this requirement is to inform publishers, reviewers and readers about any professional and/or financial relationships (such as sponsorships and corporate affiliations) with financial agents related to pharmaceutical products or equipment involved in the work that could potentially influence the interpretations and conclusions of the article. A Conflict of Interest Statement will be published at the end of every article. Bioethics of experiments on human beings: All experiments involving human beings should follow the specific resolution of the Brazilian National Health Council (no. 196/96), including signing an Informed Consent Form and protection of the research subjects’ confidentiality. In experimental studies involving human beings, the authors should indicate whether the procedures followed the ethical standards of the committee responsible for human experimentation (institutional and national) and the Declaration of Helsinki of 1975, revised in 2008. A Statement of Approval from the local ethics committee should be sent via the online system Plataforma Brasil. Studies conducted in humans must comply with ethical standards and must obtain the informed consent of the research subjects, according to Resolution 466/2012 of the National Health Council of the Brazilian Ministry of Health, which gives the Code of Ethics for Research involving Human Beings, or for authors outside Brazil, such studies must be comply with the standards of the Committee on Publication Ethics (COPE). Bioethics of experiments on animals: The work described in the article must have been conducted according to the ethical principles for animal experimentation, according to Law 11,794/08, which sets out the procedures for the scientific use of animals, and stipulates that research projects must be submitted to the research ethics committee of the Institution concerned. For more information, go to the website of the National Council for Control of Animal Experimentation (CONCEA) and the Brazilian Board of Animal Experimentation (COBEA).
Clinical Trials: RBME supports the policies of the World Health Organization (WHO) and the International Committee of Medical Journal Editors (ICMJE) for registering clinical trials, recognizing the importance of these initiatives for the international registration and dissemination of information about open-access clinical studies. Therefore, clinical research articles will only be accepted for publication if they have received an identification number in one of the Clinical Trial Registers validated by the WHO and ICMJE criteria, the email addresses for which are available on the ICMJE website. REVIEW PROCESS AND ADDITIONAL INFORMATION
Preprint: RBME accepts the submission of articles published as preprints. A preprint is a completed scientific manuscript that is deposited by the authors in a public server. It may have been previously published without having passed through a peer review and can be viewed free of charge by anyone in the world on platforms developed today for this purpose, such as the Scielo PrePrint platform. In most cases, a work published as a preprint is also submitted to a journal for peer review. Thus, preprints (not validated through peer review) and journal publications (validated through peer review) function in parallel as a communication system for scientific research.1,2 Data sharing: RBME encourages the sharing, citation and referencing of all data, program code and content underlying article texts in order to facilitate the evaluation of research, the reproducibility of studies, and the preservation and reuse of content. Data sharing can be published on the Scielo Dataverse platform.
Citations should facilitate access to research content and when articles, books, and online publications are cited, the data should be cited in an appropriate place in the text and the source included in the list of references in accordance with the Vancouver Style standards.3 All submitted articles must be typed in double space, Arial 12 font, on A4 pages, without line or paragraph numbering. Figures and tables must be presented at the end of the article, each on a separate page. The locations for insertion of tables or figures must be clearly marked in the body of the text. Numbers less than ten should be written out in full, while numbers greater than ten should be written in Arabic numerals. Articles that do not follow the instructions for authors in regard to style and format will be returned by the Editorial Board without being reviewed.
Measurements should be expressed in the International System (Système International, SI) and standard units, where applicable. It is recommended that authors do not use abbreviations in the title, and limit their use in the abstract and throughout the text. Generic names should be used for all drugs. Pharmaceutical products may be referred to by their commercial names, but the manufacturer’s name, city or country, or email address must be included in parentheses, in the Material and Methods section.
CONSORT- controlled and randomized trials Abbreviations: The use of abbreviations should be kept to a minimum. Abbreviations should be defined when used for the first time in the abstract and also in the text. Non-standard abbreviations should not be used, unless they appear at least three times in the text. Units of measurement (3 ml or 3 mL, not 3 milliliters) or standard scientific symbols (e.g., Na for sodium) are not considered abbreviations, and therefore do not need to be defined. Abbreviate chemical substances and terms used for therapeutic combinations. Abbreviations on figures and tables may be used if space is limited, but should be defined in the caption, even if they have been defined in the text of the article itself.
Authors: We strongly recommend up to 6 authors per article. In exceptional cases, we will permit up to a maximum of 10 authors.
All articles must include a description of the authors' contributions, using the following model: Abstract: Each article must include abstracts in Portuguese, English and Spanish. Each version of the abstract should contain no more than 300 words. A structured version is mandatory for original articles, and must include an introduction, objectives, methods, results and conclusion. Review articles and other types of article do not require a structured abstract. Abstracts should include the Level of Evidence and the Type of Study, according to the classification table annexed at the end of this text. The following segmented information, up to 1 paragraph in length, must also be included before the structured abstract in English and in the submission: a) Study Design and b) Clinical Relevance Statement.
Keywords: The article must include no fewer than three and no more than six keywords, in the Portuguese, English and Spanish versions, based on the Health Sciences Descriptors (DeCS), or the Medical Subject Headings (MeSH) of the National Library of Medicine, available in , or based on the Medical Subject Headings (MeSH) of the Index Medicus.
Important: When reporting experiments involving humans or animals, indicate whether the procedures followed the norms of the Ethical Committee on Human Experiments of the institution where the research was conducted, and whether the procedures are in accordance with the Helsinki Declaration of 1995 and Animal Experimentation Ethics, respectively. Authors should include a statement indicating that the protocol was approved by the Ethics Committee of the Institution (the institution with which at least one of the authors is affiliated), with the respective identification number. It should also mention that an Informed Consent Form was signed by all the study subjects.
1) standard journal article
2) Institutional Author
3) Book with author(s) responsible for the entire content
4) Book with editor(s) as author(s)
5) Book chapter
6) Electronic Material
7) Data Sharing:
Transinf. [Internet]. 2009. Available at: https://doi.org/10.1590/S0103-37862009000300003. Write [dataset] immediately before the reference so we can identify it properly as a data reference. The identifier [dataset] will not appear in the published article. Please note that it is the author’s responsibility to obtain permission from the copyright holder to reproduce figures (or tables) that have previously been published in other sources. According to the principles of open access, the authors must have permission from the copyright holder if they wish to include images that have been published in other unopened access journals. This permission must be indicated in the captions to figures, and the original source must be included in the list of references.
Videos: The submission of videos is optional, and will accompany the online version of the article. Videos should be submitted together with the article, in a separate file, accompanied by a caption. Videos must be sent in MP4 digital format. Original Article: RBME accepts all kinds of original research in the areas of Exercise and Sports Sciences and Medicine, including research involving human beings, and experimental research. The article should contain the following items: a structured Abstract, keywords, Introduction, Materials and Methods, Results, Discussion, and Conclusions. Review Articles: Review Articles should address specific topics in order to update readers on specific themes, topics or issues in the areas of Medicine and Exercise and Sport Sciences. The Editorial Board will evaluate the quality of the article, the relevance of the chosen theme, and the proven merit of the authors in the specific area addressed. If any of the above items is deemed inadequate, the article will be rejected by the editors, without being submitted to a peer review. Systematic Review/update/meta-analysis: RBME encourages authors to submit systematic literature review articles in the areas of Exercise and Sports Sciences and Medicine. The Editorial Board will evaluate the quality of the article, the relevance of the chosen theme, the bibliographic search procedure, the criteria for inclusion of the articles and the statistical treatment used. If any of the above items is deemed inadequate, the article will be rejected by the editors, without being submitted to a peer review. Case Report: Specific clinical cases that bring relevant and illustrative information about the diagnosis or treatment of a particular case that is rare in Exercise and Sport Medicine. The articles must be objective and accurate, and must include the following: abstract; introduction; an objective report containing the history, physical examination and findings of complementary exams, as well as treatment and follow-up; discussion, explaining in detail the clinical implications of the case in question, and comparing with the literature, highlighting similar cases reported in the literature; bibliographic references. Letter to the editor: Letters addressed to the Chief Editor of RBME will be considered for publication if they promote intellectual discussion about a particular article that was recently published in the journal. Letters to the editor must include an informative title and follow the instructions above for publication. They must be no longer than 500 words. If accepted, a copy will be sent to the author of the original article that prompted the discussion, inviting him or her to submit a replica that will be published along with the letter. |
Manuscripts Sending
Submission of articles: Since January 2008, RBME has adopted the SciELO online Publication and Submission System available at https://mc04.manuscriptcentral.com/rbme-scielo. Authors should follow the registration instructions and include the articles in the system itself.
|
Levels of evidence for primary research questions
[This chart was adapted from material published by the Centre for Evidence-Based Medicine, Oxford, UK. For more information, please see www.cebm.net.] |
Type of Studies
Level |
Therapeutic Studies— |
Prognostic Studies— |
Diagnostic Studies— |
Economic and Decision |
I |
High quality randomized trial with statistically |
High quality prospective study d (all patients were enrolled at the same point in their disease with ≥80% |
Testing of previously developed diagnostic criteria on consecutive patients |
Sensible costs and alternatives; values obtained from many studies; with |
II |
Lesser quality RCT (eg, < 80% followup, no blinding, or improper |
Retrospectivefstudy |
Development of diagnostic criteria on consecutive patients (with universally applied reference ‘‘gold’’ standard) |
Sensible costs and lternatives; values obtained from limited studies; with multiway sensitivity analyses |
III |
Case control studyg |
Case control studyg |
Study of nonconsecutive patients; without consistently applied reference ‘‘gold’’ standard |
Analyses based on limited alternatives and costs; and |
IV |
Case seriesh |
Case series |
|
Analyses with no sensitivity analyses |
V |
Expert opinion |
Expert opinion |
Expert opinion |
Expert opinion |
Sources: |